EA200300007A1 - COMPOSITION FOR THE TREATMENT OF FLU, METHOD FOR ITS STABILIZATION - Google Patents
COMPOSITION FOR THE TREATMENT OF FLU, METHOD FOR ITS STABILIZATIONInfo
- Publication number
- EA200300007A1 EA200300007A1 EA200300007A EA200300007A EA200300007A1 EA 200300007 A1 EA200300007 A1 EA 200300007A1 EA 200300007 A EA200300007 A EA 200300007A EA 200300007 A EA200300007 A EA 200300007A EA 200300007 A1 EA200300007 A1 EA 200300007A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- composition
- influenza
- drug
- flu
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 230000006641 stabilisation Effects 0.000 title abstract 2
- 238000011105 stabilization Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 5
- 206010022000 influenza Diseases 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- 208000006820 Arthralgia Diseases 0.000 abstract 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 230000002008 hemorrhagic effect Effects 0.000 abstract 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract 1
- 235000005493 rutin Nutrition 0.000 abstract 1
- 229960004555 rutoside Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к медицине и фармацевтике. Оно предназначено для лечения гриппа. За счет стабилизации композиции ее можно производить промышленным способом. Комплексный лекарственный препарат обладает действием на основные симптомы гриппа: лихорадку, головную боль, суставные и мышечные боли, гемморрагические проявления, ринит, кашель, обладает жаропонижающим, противовоспалительным, противовирусным, антиаллергическим, общеукрепляющим действием за счет входящих в него компонентов. Композиция состоит из аскорбиновой кислоты, анальгина, ацетилсалициловой кислоты, рутина, димедрола, солей кальция. Предлагаемый комплексный препарат обладает способностью влиять на репродукцию вирусов гриппа A и B. Препарат - для перорального приема. При лечении гриппа предлагаемой композицией сроки лечения гриппа сокращаются на 2-3 дня. Композиция по изобретению обладает длительным сроком хранения, т.е. стабильна. Этого достигают тем, что несовместимые химически компоненты смеси разнесены в две разные капсулы или таблетки, которые при одновременном приеме дают терапевтический эффект.The invention relates to medicine and pharmaceuticals. It is intended for the treatment of influenza. Due to the stabilization of the composition it can be produced industrially. The complex drug has an effect on the main symptoms of the flu: fever, headache, joint and muscle pain, hemorrhagic manifestations, rhinitis, cough, has antipyretic, anti-inflammatory, antiviral, antiallergic, tonic effect due to its constituents. The composition consists of ascorbic acid, analgin, acetylsalicylic acid, rutin, Dimedrol, calcium salts. The proposed complex drug has the ability to influence the reproduction of influenza viruses A and B. The drug is for oral administration. In the treatment of influenza with the proposed composition, the terms of treatment of influenza are reduced by 2-3 days. The composition according to the invention has a long shelf life, i.e. is stable. This is achieved by the fact that the chemically incompatible components of the mixture are separated into two different capsules or tablets, which, when taken simultaneously, give a therapeutic effect.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2001133079/15A RU2234922C2 (en) | 2001-12-10 | 2001-12-10 | Anti-influenza complex preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200300007A1 true EA200300007A1 (en) | 2003-08-28 |
| EA009896B1 EA009896B1 (en) | 2008-04-28 |
Family
ID=33412185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200300007A EA009896B1 (en) | 2001-12-10 | 2003-01-05 | Composition for the treatment of influenza, method for stabilizing thereof |
Country Status (2)
| Country | Link |
|---|---|
| EA (1) | EA009896B1 (en) |
| RU (1) | RU2234922C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2245157C2 (en) * | 2001-08-09 | 2005-01-27 | Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" (ООО "ЛЕОВИТ нутрио") | Biologically active additive for preventing and treating flu cases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2034533C1 (en) * | 1993-02-25 | 1995-05-10 | Химико-фармацевтическое акционерное общество открытого типа "Октябрь" | Analgesic antipyretic medicinal agent and a method of its preparing |
| RU2173555C2 (en) * | 1998-01-28 | 2001-09-20 | Открытое акционерное общество "Уралбиофарм" | Method of preparing anti-inflammatory analgetic agent |
| RU2192248C2 (en) * | 1998-07-13 | 2002-11-10 | Товарищество с ограниченной ответственностью фирма "Эйкос" | Preparation "antiagrippin" |
| RU2138252C1 (en) * | 1999-02-05 | 1999-09-27 | Закрытое Акционерное Общество "Простанорм" | Combined preparation "tetralgin" showing analgetic and antipyretic effect |
-
2001
- 2001-12-10 RU RU2001133079/15A patent/RU2234922C2/en active
-
2003
- 2003-01-05 EA EA200300007A patent/EA009896B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA009896B1 (en) | 2008-04-28 |
| RU2234922C2 (en) | 2004-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030823A1 (en) | DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT | |
| CO4950524A1 (en) | NITRIC ACID SINTASA INHIBITORS | |
| ATE438383T1 (en) | METHOD FOR PRODUCING TANNATE TABLETS, CAPSULES OR OTHER SOLID DOSAGE FORMS | |
| AR037490A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES | |
| CY1112115T1 (en) | PHAINEOXIC ACID PRODUCERS USEFUL FOR THE THERAPEUTIC RESPONSE TO RESPIRATORY DISEASES | |
| CY1115940T1 (en) | Derivatives of Substituted Phenylalkanoic Acid and Their Use for Therapeutic Treatment of Respiratory Diseases | |
| NO20064347L (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives | |
| TW200510375A (en) | New compounds | |
| ATE60234T1 (en) | DIETICAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING METHYLSULFONYLMETHANE. | |
| BR0211794A (en) | Pharmaceutical composition and method for masking the taste of at least one unpleasant tasting pharmaceutically active compound | |
| NO20034863L (en) | Deuterated 3-piperidinopropiophenone as well as drugs containing these compounds | |
| NO20044107L (en) | Medicines containing betamimetics and a new anticholinergic drug | |
| AR030039A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES A SELECTIVE INHIBITOR DRUG OF CYCLOOXYGENASA-2, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR PREVENT AFFECTIONS THROUGH CYCLOOXYGENASE-2 AND METHOD TO MAKE SUCH MEDICINAL PRODUCT | |
| SE0102440D0 (en) | New compound | |
| EA200401303A1 (en) | MEDICINES CONTAINING STEROIDS AND NEW ANTICHOLINERGIC MEANS | |
| MXPA05008403A (en) | Use of edible acid in fast-dispersing pharmaceutical solid dosage forms. | |
| AR012737A1 (en) | TRIPTOLIDE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES AND USES IN THE MANUFACTURE OF MEDICINES | |
| EA200300007A1 (en) | COMPOSITION FOR THE TREATMENT OF FLU, METHOD FOR ITS STABILIZATION | |
| GB0228552D0 (en) | Chemical compounds | |
| BRPI0415322A (en) | antiretroviral pharmaceutical composition, process for the preparation of an antiretroviral pharmaceutical composition, method for reducing the burden of pill consumption for a patient, method for increasing lamivudine and zidovudine half-life while not affecting nevirapine half-life | |
| WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption | |
| ATE413187T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU | |
| WO2002069968A8 (en) | New use | |
| AR008245A1 (en) | DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES | |
| EA200501621A1 (en) | ANTIGRIPOUS AGENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Withdrawal of a eurasian application | ||
| NF9A | Restoration of lapsed right to a eurasian application |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |
|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| QB4A | Registration of a licence in a contracting state | ||
| QB4A | Registration of a licence in a contracting state | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| PC4A | Registration of transfer of a eurasian patent by assignment |